0.03
+0(+0.00%)
Currency In USD
Address
3950 South Country Club Road
Tucson, AZ 85714
United States of America
Phone
520 365 3100
Sector
Healthcare
Industry
Medical - Devices
Employees
107
First IPO Date
April 07, 1994
| Name | Title | Pay | Year Born |
| Mr. Jack Phillips | Chief Executive Officer, President & Director | 595,000 | 1966 |
| Mr. David Patience | Chief Financial Officer | 316,438 | 1986 |
| Mr. Lawrence Michael Mertz | Chief Technology Officer | 340,847 | 1963 |
| Mr. John Meduri | Chief Strategy Officer | 0 | N/A |
| Ms. Laura Pierson | Investor Relations Officer | 0 | N/A |
| Ms. Maya Gowri | Senior Vice President & Head of Operations | 0 | N/A |
| Mr. Chris Thode | Senior Vice President of US Commercial | 0 | N/A |
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.